Promising Gene Therapy Using an Adenovirus Vector Carrying REIC/Dkk-3 Gene for the Treatment of Biliary Cancer.

Current Gene Therapy
Emi TanakaHiroyuki Okada

Abstract

We previously demonstrated that the reduced expression in immortalized cells (REIC)/dikkopf-3 (Dkk-3) gene was downregulated in various malignant tumors, and that an adenovirus vector carrying the REIC/Dkk-3 gene, termed Ad-REIC induced cancer-selective apoptosis in pancreatic cancer and hepatocellular carcinoma. In this study, we examined the therapeutic effects of Ad-REIC in biliary cancer using a second- generation Ad-REIC (Ad-SGE-REIC). Human biliary cancer cell lines (G-415, TFK-1) were used in this study. The cell viability and apoptotic effect of Ad-SGE-REIC were assessed in vitro using an MTT assay and Hoechst staining. The anti-tumor effect in vivo was assessed in a mouse xenograft model. We also assessed the therapeutic effects of Ad-SGE-REIC therapy with cisplatin. Cell signaling was assessed by Western blotting. Ad-SGE-REIC reduced cell viability, and induced apoptosis in biliary cancer cell lines via the activation of the c-Jun N-terminal kinase pathway. Ad-SGE-REIC also inhibited tumor growth in a mouse xenograft model. This effect was further enhanced in combination with cisplatin. Ad-SGE-REIC induced apoptosis and inhibited tumor growth in biliary cancer cells. REIC/Dkk-3 gene therapy using Ad-SGE-REIC is an att...Continue Reading

References

Feb 1, 2000·Biochemical and Biophysical Research Communications·T TsujiM Namba
Aug 21, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T AndréUNKNOWN GERCOR Group
Feb 13, 2009·International Journal of Oncology·Masami WatanabeHiromi Kumon
Apr 9, 2010·The New England Journal of Medicine·Juan ValleUNKNOWN ABC-02 Trial Investigators
May 13, 2011·The New England Journal of Medicine·Thierry ConroyUNKNOWN PRODIGE Intergroup
Oct 18, 2013·The New England Journal of Medicine·Daniel D Von HoffMarkus F Renschler
Jan 1, 2014·Journal of Gastroenterology and Hepatology·Daisuke UchidaKazuhide Yamamoto
May 30, 2015·Journal of Hematology & Oncology·Milind JavleAbby B Siegel
Jun 2, 2015·The New England Journal of Medicine·Dung T LeLuis A Diaz
Mar 31, 2016·Japanese Journal of Clinical Oncology·Junki MizusawaUNKNOWN Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group
Jan 23, 2017·Current Gastroenterology Reports·Bryan DohertyWilliam C Palmer
Aug 23, 2017·Cancer Letters·Mengyu FengYupei Zhao
Oct 11, 2017·Nature Reviews. Clinical Oncology·Sumera RizviGregory J Gores
Nov 29, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Milind JavleTanios Bekaii-Saab
Jan 9, 2019·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Jan 15, 2019·Alimentary Pharmacology & Therapeutics·Maria Angeles Gonzalez-CarmonaTobias J Weismüller
Jun 4, 2019·The New England Journal of Medicine·Talia GolanHedy L Kindler
Sep 6, 2019·Chinese Clinical Oncology·Milind JavleGhassan K Abou-Alfa
Jan 8, 2020·The Lancet Oncology·Sri Harsha TellaAmit Mahipal
Jan 14, 2020·Hepatobiliary Surgery and Nutrition·Pingzhou YangXu Che
Oct 1, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D SakaiT Ioka

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.